In-person examination important for skin cancer detection

This article originally appeared here.
Share this content:
Teledermatology Implications for Incidental Skin CA Detection
Teledermatology Implications for Incidental Skin CA Detection

(HealthDay News) -- An in-person skin examination is important for detection of incidentally-identified skin malignancies, according to a review published in the April issue of the Journal of the American Academy of Dermatology.

Jaime L. Kingsley-Loso, from the University of Minnesota Medical School in Minneapolis, and colleagues retrospectively reviewed the medical charts of all dermatology consults at the Minneapolis Department of Veterans Affairs Medical Center over 8.25 years.

Of the 17,174 included consults; the researchers found that 2,257 patients (13.1 percent) had one or more biopsied incidental lesions. Of the 3,328 biopsied incidental lesions, half were malignant (this included 1,187 patients). For an incidental malignant lesion, the per-person detection rate was 6.9 percent. In 84 patients there were 87 incidental melanomas identified (a per-person detection rate of 0.5 percent). For biopsied incidental malignancies, the most frequent anatomical location was the head and neck (53.9 percent), with incidental melanomas most frequently located on the back (33.3 percent).

"An in-person skin examination by a trained dermatologist is important for detection of skin malignancies," the authors write. "This may have implications for teledermatology."

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs